Open AccessRecombinant plant‐expressed tumour‐associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice
Author(s) -
Pinkhasov Julia,
Alvarez M. Lucrecia,
Rigano M. Manuela,
Piensook Khanrat,
Larios Dalia,
Pabst Martin,
Grass Josephine,
Mukherjee Pinku,
Gendler Sandra J.,
Walmsley Amanda M.,
Mason Hugh S.
Publication year - 2011
Publication title -
plant biotechnology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.525
H-Index - 115
eISSN - 1467-7652
pISSN - 1467-7644
DOI - 10.1111/j.1467-7652.2011.00614.x
Subject(s) - muc1 , biology , epitope , antigen , glycosylation , antigenicity , glycan , monoclonal antibody , microbiology and biotechnology , antibody , glycoprotein , biochemistry , immunology
Summary The human epithelial mucin MUC1 is a heavily glycosylated transmembrane protein that is overexpressed and aberrantly glycosylated on over 90% of human breast cancers. The altered glycosylation of MUC1 reveals an immunodominant peptide along its tandem repeat (TR) that has been used as a target for tumour immunotherapy. In this study, we used the MUC1 TR peptide as a test antigen to determine whether a plant‐expressed human tumour‐associated antigen can be successfully expressed in a plant system and whether it will be able to break self‐antigen tolerance in a MUC1‐tolerant mouse model. We report the expression of MUC1 TR peptide fused to the mucosal‐targeting Escherichia coli enterotoxin B subunit (LTB‐MUC1) in a plant host. Utilizing a rapid viral replicon transient expression system, we obtained high yields of LTB‐MUC1. Importantly, the LTB‐MUC1 fusion protein displayed post‐translational modifications that affected its antigenicity. Glycan analysis revealed that LTB‐MUC1 was glycosylated and a MUC1‐specific monoclonal antibody detected only the glycosylated forms. A thorough saccharide analysis revealed that the glycans are tri‐arabinans linked to hydroxyprolines within the MUC1 tandem repeat sequence. We immunized MUC1‐tolerant mice (MUC1.Tg) with transiently expressed LTB‐MUC1, and observed production of anti‐MUC1 serum antibodies, indicating breach of tolerance. The results indicate that a plant‐derived human tumour‐associated antigen is equivalent to the human antigen in the context of immune recognition.